Akèy › Rezistans Insilin
Etid klinik pou Rezistans Insilin ap rekrite nan Etazini
100 etid pou Rezistans Insilin ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY7 etid
- Aurora, CO7 etid
- Boston, MA6 etid
- St. Louis, MO6 etid
- San Francisco, CA5 etid
- Baltimore, MD4 etid
- Baton Rouge, LA4 etid
- Nashville, TN4 etid
- Washington, DC4 etid
- Mountain View, CA4 etid
- Ann Arbor, MI4 etid
- New Haven, CT4 etid
- Indianapolis, IN4 etid
- Durham, NC3 etid
- Fort Collins, CO3 etid
- Salt Lake City, UT3 etid
- Miami, FL3 etid
- Charlottesville, VA3 etid
- Philadelphia, PA3 etid
- Rochester, MN3 etid
- Houston, TX3 etid
Pa eta
- Alabama3 etid
- Colorado9 etid
- Connecticut4 etid
- Florid6 etid
- Indiana4 etid
- Kalifòni11 etid
- Lwizyàn4 etid
- Maryland7 etid
- Massachusetts8 etid
- Michigan6 etid
- Minnesota5 etid
- Missouri7 etid
- New York11 etid
- North Carolina5 etid
- Pennsylvania6 etid
- Tennessee5 etid
- Texas11 etid
- Utah4 etid
- Virginia4 etid
- Washington4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Tirzepatide in Obesity-Driven Endometrial Cancer
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Fanm · Mizajou Oct 2, 2026 · NCT07065552Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
Ap rekrite
Laj 55 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT06274749Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07087184Effects of Pistachios on Postprandial Metabolic Responses in Adults With Overweight or Obesity
Ap rekrite
Laj 18 a 35 · Tout sèks · Mizajou Oct 2, 2026 · NCT07853898Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Oct 1, 2026 · NCT07224334Effects of Hourly Stair-Climbing Exercise Snacks on Metabolic and Vascular Health in Adults With Prediabetes
Ap rekrite
Laj 18 a 69 · Tout sèks · Mizajou Sep 29, 2026 · NCT07847684A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 29, 2026 · NCT07223333Insomnia and Insulin Resistance
Ap rekriteVolontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Sep 24, 2026 · NCT07333586Tirzepatide for Treatment of CCCA
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07734870Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT01143480Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 45 · Tout sèks · Mizajou Sep 18, 2026 · NCT07494084Type 1 Diabetes Extension Study
Ap rekriteEtid obsèvasyon
Laj 8 a 35 · Tout sèks · Mizajou Sep 18, 2026 · NCT02734277Taste Bud-Derived Stem Cells in Humans
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 120 · Tout sèks · Mizajou Sep 16, 2026 · NCT03366168Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury
Ap rekriteFaz 1
Laj 18 a 84 · Tout sèks · Mizajou Sep 15, 2026 · NCT07384052Graded Insulin Suppression Test P&F
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 8, 2026 · NCT06592261Alpelisib Challenge Test (ACT)
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 3, 2026 · NCT07778524Prenatal Exercise and Glucose Regulation
Ap rekriteVolontè an sante akeyi
Laj 18 a 35 · Fanm · Mizajou Sep 3, 2026 · NCT07802262Peanuts for Cardiometabolic, Brain, and Intestinal Health
Ap rekrite
Laj 20 a 59 · Tout sèks · Mizajou Sep 2, 2026 · NCT06867198Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
Ap rekrite
Laj 20 a 65 · Fanm · Mizajou Sep 2, 2026 · NCT06735651Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Aug 28, 2026 · NCT07553325Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599982Human Models of Selective Insulin Resistance: Alpelisib, Part I
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Aug 24, 2026 · NCT06354088Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Aug 24, 2026 · NCT06042517Genetic Studies of Insulin and Diabetes
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
6 Months – 120 Years · Tout sèks · Mizajou Aug 24, 2026 · NCT00001987Genetic of Skeletal Muscle Insulin Resistance
Ap rekriteVolontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Aug 24, 2026 · NCT07780513Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.